Structure

InChI Key NLYNIRQVMRLPIQ-XQLAAWPRSA-N
Smiles CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
InChI
InChI=1S/C17H28O5/c1-5-18-14-11(3)13-7-6-10(2)12-8-9-16(4)20-15(19-14)17(12,13)22-21-16/h10-15H,5-9H2,1-4H3/t10-,11-,12+,13+,14+,15-,16-,17-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H28O5
Molecular Weight 312.41
AlogP 3.23
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 2.0
Polar Surface Area 46.15
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 22.0
Assay Description Organism Bioactivity Reference
Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 Plasmodium falciparum 2.7 nM
Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 Plasmodium falciparum 1.4 nM
In vitro antimalarial activity against Plasmodium falciparum FCR3 Plasmodium falciparum 0.0013 ug.mL-1
In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 Plasmodium falciparum 0.0001 ug.mL-1
In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 Plasmodium falciparum 0.0001 ug.mL-1
In vitro antimalarial activity against drug-resistant Plasmodium falciparum D6 Plasmodium falciparum 0.00034 ug.mL-1
In vitro antimalarial activity against drug-resistant Plasmodium falciparum W-2 Plasmodium falciparum 0.00018 ug.mL-1
In vitro antimalarial activity against mefloquine-resistant Plasmodium falciparum D6 (Sierra Leone) Plasmodium falciparum 0.00087 ug.mL-1
In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 (Indochina) Plasmodium falciparum 0.00016 ug.mL-1
In vitro inhibitory activity against Plasmodium falciparum (sierra leone clone) Plasmodium falciparum 0.00127 ug.mL-1
Inhibitory concentration against Plasmodium falciparum D6 (Sierra Leone) Plasmodium falciparum 4.07 nM
Inhibitory concentration against Plasmodium falciparum W2 Indochina Plasmodium falciparum 2.94 nM
Intrinsic equimolar activity against Plasmodium falciparum D6 (Sierra Leone) relative to QHS Plasmodium falciparum 2.58 nM
Intrinsic equimolar activity against Plasmodium falciparum W2 Indochina relative to QHS Plasmodium falciparum 2.18 nM
In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum African D6 Plasmodium falciparum 2.7 nM
In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum W2 Indochina Plasmodium falciparum 1.4 nM
Antiangiogenic activity at chorioallantoic membrane of chick embryo at 5 nmol per egg Gallus gallus 29.0 %
Antifungal activity against Candida albicans ATCC 90028 by modified NCCLS method Candida albicans 15.0 ug.mL-1
Antifungal activity against Cryptococcus neoformans ATCC 90113 by modified NCCLS method Cryptococcus neoformans 0.085 ug.mL-1
Antimalarial activity against chloroquine, mefloquine and halofantrine-resistant Plasmodium yoelii nigeriensis infected in Swiss mouse assessed as suppression of parasitemia at 24 mg/kg, po administered for 4 days measured on day 4 Plasmodium yoelii nigeriensis 100.0 %
Antimalarial activity against chloroquine, mefloquine and halofantrine-resistant Plasmodium yoelii nigeriensis infected in Swiss mouse assessed as suppression of parasitemia at 48 mg/kg, po administered for 4 days measured on day 4 Plasmodium yoelii nigeriensis 100.0 %
Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by SYBR Green I-based fluorescence assay Plasmodium falciparum K1 1.08 nM
Antimalarial activity against schizont stage of chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by SYBR Green I-based fluorescence assay Plasmodium falciparum 1.37 nM
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens -6.36 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 20.55 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.16 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.16 %

Related Entries

Cross References

Resources Reference
ChEBI 135335
ChEMBL CHEMBL301267
DrugBank DB13851
DrugCentral 246
FDA SRS XGL7GFB9YI
Guide to Pharmacology 9958
PubChem 3000469
SureChEMBL SCHEMBL17156474
ZINC ZINC000008214360